Cao Y, Shi F, Li Y, Wei X, Yi H, Han S. Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China. Health Decision. 2024;2(S1). doi:10.54844/hd.2024.0008